GLAXO's ZOFRAN (ONDANSETRON) APPROVED FOR PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH "1-B" RATING AFTER 27-MONTH REVIEW AT FDA

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".